Compare — Georgia Financials

panel 2026-09-21Ask

FY 2023 · GEL thousands · companies ordered by revenueXLSX

Line item	CIS Pharma	Ivermedi	Mermisi	Gea	Welfare International
Total Current Assets	29,667	27,245	35,912	29,747	41,874
Total Non-Current Assets	2,109	15,135	4,784	8,620	-18,866
TOTAL ASSETS	31,776	42,380	40,696	38,366	23,009
Total Current Liabilities	13,379	6,700	6,368	8,764	13,748
Total Non-Current Liabilities	0	40	0	662	0
TOTAL LIABILITIES	13,379	6,740	6,368	9,426	13,748
Total Equity	18,396	35,640	34,329	28,940	9,261
Balance Check (Assets - L&E)	0	0	0	0	0
Total Debt	420	40	4,034	1,092	0
Cash & Equivalents	99	9,464	12,797	2,794	5
Net Debt	321	-9,424	-8,763	-1,701	-5

Peer percentile within sector

Rank on

Company	Sector	EBITDA margin · FY 2023	Percentile	Sector n
CIS Pharma	Pharma	47.4%	97th pct	123
Mermisi	Pharma	30.7%	75th pct	123
Gea	Pharma	27.8%	69th pct	123
Welfare International	Pharma	21.3%	57th pct	123
Ivermedi	Pharma	6.6%	28th pct	123

Percentile is within each company's own sector across the whole FY2023 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.